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Abstract
A diabetic patient who at a routine abdominal ultrasounds was found to have a very dilated pancreatic duct. Computed tom-
ography (CT) scan diagnosed a sero-cystic lesion of the pancreatic head. Gastroduodenoscopy discovered a duodenal hyper-
emic area, which was sampled. Biopsy demonstrated intramucosal vascular emboli from a neuroendocrine carcinoma
positive for Chromogranin A and Somatostatin and negative for Gastrin. Cholangio-magnetic resonance imaging revealed
that the sero-cystic lesion found at CT, was being mimicked by the enormously dilated pancreatic duct but suggested the
possibility of an intraductal or ampullar neoplasm. Blood and urine tests were not helpful and an octreoscan was negative.
The patient underwent surgery. Direct exploration conﬁrmed the severe pancreatic duct dilation and a cephalic lesion
requiring a pancreatoduodenectomy. Histology conﬁrmed a neuroendocrine tumor inﬁltrating the duodenum. We conclude
that despite modern sophisticated imaging and endoscopic techniques, the evaluation of bilio-pancreatic region can be chal-
lenging and can reserve surgical surprises.
INTRODUCTION
Modern imaging techniques greatly facilitate the evaluation of
bilio-pancreatic structures, however precise deﬁnition of pan-
creatic lesions can sometimes be challenging despite extensive
preoperative evaluation. We describe a case of misleading
imaging features followed by a surgical ‘surprise’ which
prompted a different surgical strategy.
CASE REPORT
A 55-year-old asymptomatic man, with type 2 diabetes mellitus
controlled by oral metformin, underwent an abdominal ultra-
sound that incidentally discovered a remarkable pancreatic
duct dilation. The pancreatic head could not be well visualized.
The patient therefore underwent a computed tomography
(CT) scan (Figs 1 and 2) that revealed ‘a thickened duodenal
wall and a sero-cystic lesion of the pancreatic head without
contrast-enhancement, which compressed the duodenal lumen
and caused a dilation of the Wirsung duct’. The liver, the gall-
bladder and the extrahepatic biliary tree were normal. No
lymphadenopathy was found.
An oesophagogastroduodenoscopy showed a normal duo-
denal bulb and descending portion of the duodenum, but at the
superior duodenal knee, a 13-mm hyperemic area was found and
sampled. The endoscopist decided at that time not to perform an
ERCP, judging as relevant the risk of bleeding. Histology revealed
vascular emboli from a neuroendocrine carcinoma within the
duodenal mucosa. Immunocytochemical tests were positive for
Chromogranin A and Somatostatin; and negative for Gastrin.
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Serum levels of CEA, CA 19-9, AFP and plasma levels of VIP,
somatostatin, gastrin and chromogranin A were normal as
were urinary levels of 5HIAA.
A Cholangio-magnetic resonance imaging (MRI) (Fig. 3)
revealed that the sero-cystic lesion found at CT, was being mim-
icked by the enormously dilated pancreatic duct that had
reached a diameter of 2 cm at the level of the pancreatic body.
The dilation decreased to 1 cm in the pancreatic tail and the
lumen of the Wirsung duct seemed to have an irregular proﬁle.
On the opposite side, the Wirsung caliber suddenly decreased in
proximity to its duodenal end. This ﬁnding was not univocal and
could suggest an intraductal mucous secreting tumor, chronic
pancreatitis or an ampullary alteration. The pancreatic paren-
chyma of the body and of the tail was remarkably hypotrophic,
and only some residual pancreatic tissue was observed at the
uncinate process. The choledochus maintained a regular size
almost down to its duodenal end, but in proximity of the Vater
ampulla it disappeared for about one cm, suggesting a functional
spasm or, more likely, a pathologic process of the ampulla. An
octreoscan did not demonstrate any somatostatin receptor.
Preoperative work-up was consistent with a neuroendocrine
pancreatic tumor, probably a somatostatinoma [1, 2].
Considering the clinical picture suggesting an ampullary
neoplasm around 1 cm in size, surgical treatment was planned
for an intended enucleation of the presumed ampullary neo-
plasm [3, 4], even if the patient was informed of the possibility
that a major pancreatic resection could be necessary and rele-
vant consensus was obtained.
At duodenotomy, we actually found a 2 × 3 cm lesion of the
pancreatic head, inﬁltrating the medial wall of the duodenum
cephalad to the papilla of Vater, that was not be amenable to a
limited resection. We therefore diverted to a duodenocefalopa
ncreasectomy with pyloric preservation according to Traverso–
Longmire.
Figure 1: CT-scan, showing a sero-cystic lesion of the pancreatic head without
contrast-enhancement, compressing the duodenal lumen and causing a dila-
tion of the Wirsung duct.
Figure 2: Another image of the CT scan, showing a sero-cystic lesion of the pan-
creatic head.
Figure 3: Cholangio-MRI, showing an enormously dilated pancreatic duct, with
the diameter of 2 cm at the level of the pancreatic body mimicking the sero-
cystic lesion found at CT.
Figure 4: The operative specimen showing a normal thin choledocus (incannu-
lated with a probe) cephalad to the tumor.
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The operative specimen showed a normal thin choledocus
(incannulated with a probe) cephalad to a fragile inhomogen-
eous area corresponding to the tumor (Fig. 4) and an enor-
mously dilated pancreatic duct (held by the forceps) (Fig. 5).
Post-operative histology conﬁrmed a neuroendocrine neo-
plasm of the ampullary region, inﬁltrating the duodenal wall as
well as the periduodenal and peripancreatic soft tissues. The
pancreatic duct was dilated to a diameter of 2.5 cm. The pan-
creatic tissue was atrophic and there was diffuse sclerosis of
the main pancreatic duct. Six out of 17 peripancreatic and peri-
duodenal lymph nodes were found to have neuroendocrine
metastases. The proliferating activity (MIB-1) was <2% with a
number of mithosis/10HPF below 2. Immunohistochemical
staining was positive for synaptophysin and somatostatin and
was negative for insulin, glucagon and pancreatic polypeptide.
Post-operative course was uneventful and the patient was
discharged on the 11th post-operative day.
DISCUSSION AND CONCLUSIONS
Even with the more advanced and sophisticated diagnostic
imaging, endoscopic, immunological and nuclear techniques,
evaluation of the ampullary region of the pancreas can be difﬁ-
cult and strict relationships among remarkably altered adjacent
anatomic structures can be misleading [5, 6]. In this case, the
lesion was interpreted by CT as a sero-cystic neoplasm, then
recognized by MRI as a large dilation of the Wirsung and ﬁnally,
only at duodenotomy, the cause of the Wirsung dilation could
be deﬁned. The treatment plan was consequently diverted to a
duodenopancreasectomy.
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Figure 5: The enormously dilated pancreatic duct (held by the forceps).
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